EcoDrugPlus

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d

Ensembl ID : ENSMZEG00005012116
Gene Symbol: LOC101485620
3 Cross references
211 Possible Orthologues:

Voltage-Dependent N-Type Calcium Channel Subunit Alpha-1b

Ensembl ID : ENSMZEG00005005128
Gene Symbol: LOC101486272
3 Cross references
219 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit

Ensembl ID : ENSMZEG00005011516
Gene Symbol: LOC101478451
2 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSMZEG00005013081
Gene Symbol: LOC101482156
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit

Ensembl ID : ENSMZEG00005002362
Gene Symbol: LOC101471937
3 Cross references
182 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit

Ensembl ID : ENSMZEG00005002392
Gene Symbol: LOC101474381
3 Cross references
184 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSMZEG00005012009
Gene Symbol: XDH
3 Cross references
208 Possible Orthologues:

Ensembl ID : ENSMZEG00005025813
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSMZEG00005019402
Gene Symbol: -
Cross references: -
83 Possible Orthologues:

Ensembl ID : ENSMZEG00005019406
Gene Symbol: -
Cross references: -
83 Possible Orthologues:

Ensembl ID : ENSMZEG00005019413
Gene Symbol: -
Cross references: -
83 Possible Orthologues:

Ensembl ID : ENSMZEG00005000930
Gene Symbol: -
Cross references: -
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).